Advancing accessible medicines through science and quality

Pabbati Bhaskar Reddy has 24 years of experience in pharmaceutical operations and has been associated with Hetero since August 3, 2009, where he serves as Director - Operations (Formulations).

Mr. Reddy earned a master's degree in pharmaceutical technology from the Department of Pharmaceutical Sciences, College of Engineering, Andhra University, Visakhapatnam. Before Hetero, he worked with Dr. Reddy's Laboratories, Orchid, Ranbaxy, and Jubilant.

His experience spans formulation manufacturing operations, quality, regulatory affairs, research and development, projects, environmental management, administration, and costing. He has led operations across Hetero formulation units and driven initiatives at sites in Hyderabad and Vemgal, Bengaluru.

Vasu Sabbella serves as Chief Financial Officer and a Board Member of Evaric Pharmaceuticals Inc., roles he has held since the company's inception. He is a board-certified finance and corporate legal professional with more than 25 years of experience in the pharmaceutical industry.

As a senior finance executive, Mr. Sabbella brings deep expertise across core finance, accounting, and commercial operations. His experience includes business performance management, strategic planning, complex business collaborations, mergers and acquisitions, strategic cost management and restructuring, financial process automation, profitability improvement, and disciplined capital allocation.

His areas of specialization include corporate and business finance, Financial Planning & Analysis (FP&A), financial accounting and reporting, working capital management, investment appraisal, transfer pricing, and bidding for U.S. government and institutional contracts, including FSS listing procedures.

An accomplished pharmaceutical manufacturing leader with more than 20 years of experience in large-scale operations, Ravindra Rao Konakanchi is recognized for building high-performing teams, driving regulatory compliance, and delivering multimillion-dollar cost savings across highly regulated, fast-paced environments.

He has overseen the manufacturing of more than 6 billion solid oral doses annually, successfully launched over 40 ANDA products, and led multiple FDA, DEA, and customer audits with zero critical observations. His expertise includes optimizing operational frameworks, executing technology transfers, and embedding continuous improvement systems that enhance safety, compliance, and output.

A decisive and proactive strategist, Mr. Konakanchi works at the intersection of operations, quality, engineering, and supply chain, translating enterprise goals into frontline execution with measurable results. He is passionate about team development, process integrity, and data-driven performance management.